News
12m
Asianet Newsable on MSNNovo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance.
Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop ...
Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain ...
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results